John Littlechild
Managing Director & General Partner @ HealthCare Ventures
John Littlechild is a startup investor at HealthCare Ventures. John Littlechild has been a managing director of HealthCare Ventures since 1992. He has been in the venture capital industry since 1980 when he joined Citicorp Venture Capital in London. He subsequently joined the Advent Group, opening the London office of Advent U.K. and then became the founding general partner of Advent International in Boston.Prior to his career in venture capital, he held marketing and financial management positions with Rand, Xerox and ICI. Mr. Littlechild is a member of the board of fellows of the Council for Harvard Medicine. He received his Master in Business Administration degree from Manchester Business School.
Last updated:
For AI agents: llms.txt
About HealthCare Ventures
HealthCare Ventures is a leading life science venture capital firm investing in pre-clinical or early clinical stage, focused companies with potential to transform patient care.
HealthCare Ventures Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
John Littlechild
Managing Director & General Partner
|
|||
|
Christopher K. Mirabelli
Managing Director
|
|||
Douglas E. Onsi
Managing Director
|
|||
Harold Werner
Co-Founder & Managing Director
|
|||
James H. Cavanaugh
Managing Director
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
FAQ
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
